The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial
Open accessAbstract
Importance: Results of studies on use of prophylactic haloperidol in critically ill adults are inconclusive, especially in patients at high risk of delirium. Objective: To determine whether prophylactic use of haloperidol improves survival among critically ill adults at high risk of delirium, which was defined as an anticipated intensive care unit (ICU) stay of at least 2 days. Design, Setting, and Participants: Randomized, double-blind, placebo-controlled investigator-driven study involving 1789 critically ill adults treated at 21 ICUs, at which nonpharmacological interventions for delirium prevention are routinely used in the Netherlands. Patients without delirium whose expected ICU stay was at least a day were included. Recruitment was from July 2013 to December 2016 and follow-up was conducted at 90 days with the final follow-up on March 1, 2017. Interventions: Patients received prophylactic treatment 3 times daily intravenously either 1 mg (n = 350) or 2 mg (n = 732) of haloperidol or placebo (n = 707), consisting of 0.9% sodium chloride. Main Outcome and Measures: The primary outcome was the number of days that patients survived in 28 days. There were 15 secondary outcomes, including delirium incidence, 28-day delirium-free and coma-free days, duration of mechanical ventilation, and ICU and hospital length of stay. Results: All 1789 randomized patients (mean, age 66.6 years [SD, 12.6]; 1099 men [61.4%]) completed the study. The 1-mg haloperidol group was prematurely stopped because of futility. There was no difference in the median days patients survived in 28 days, 28 days in the 2-mg haloperidol group vs 28 days in the placebo group, for a difference of 0 days (95% CI, 0-0; P = .93) and a hazard ratio of 1.003 (95% CI, 0.78-1.30, P=.82). All of the 15 secondary outcomes were not statistically different. These included delirium incidence (mean difference, 1.5%, 95% CI, -3.6% to 6.7%), delirium-free and coma-free days (mean difference, 0 days, 95% CI, 0-0 days), and duration of mechanical ventilation, ICU, and hospital length of stay (mean difference, 0 days, 95% CI, 0-0 days for all 3 measures). The number of reported adverse effects did not differ between groups (2 [0.3%] for the 2-mg haloperidol group vs 1 [0.1%] for the placebo group). Conclusions and Relevance: Among critically ill adults at high risk of delirium, the use of prophylactic haloperidol compared with placebo did not improve survival at 28 days. These findings do not support the use of prophylactic haloperidol for reducing mortality in critically ill adults. Trial Registration: clinicaltrials.gov Identifier: NCT01785290.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
Ely, E. W. (2004) · JAMA · doi:10.1001/jama.291.14.1753 · Cited by 3,073
Ely, E. W., Margolin, R., Francis, J., May, L., Truman, B., Dittus, R., Speroff, T., Gautam, S., Bernard, G. R., & Inouye, S. K. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00012 · Cited by 2,422
Intensive Care Delirium Screening Checklist: evaluation of a new screening tool
Bergeron, N., Dubois, M.-J., Dumont, M., Dial, S., & Skrobik, Y. (2001) · Intensive Care Medicine · doi:10.1007/s001340100909 · Cited by 1,487
Delirium as a predictor of long-term cognitive impairment in survivors of critical illness
Girard, T. D., Jackson, J. C., Pandharipande, P. P., Pun, B. T., Thompson, J. L., Shintani, A. K., Gordon, S. M., Canonico, A. E., Dittus, R. S., Bernard, G. R., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e47be1 · Cited by 1,213
The impact of delirium in the intensive care unit on hospital length of stay
Ely, E., Gautam, S., Margolin, R., Francis, J., May, L., Speroff, T., Truman, B., Dittus, R., Bernard, G., & Inouye, S. (2001) · Intensive Care Medicine · doi:10.1007/s00134-001-1132-2 · Cited by 1,038
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Cooper, R. (2017) · KNOWLEDGE ORGANIZATION · doi:10.5771/0943-7444-2017-8-668 · Cited by 747
Kalisvaart, K. J., De Jonghe, J. F. M., Bogaards, M. J., Vreeswijk, R., Egberts, T. C. G., Burger, B. J., Eikelenboom, P., & Van Gool, W. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53503.x · Cited by 647
Gusmao-Flores, D., Salluh, J. I. F., Chalhub, R. Á., & Quarantini, L. C. (2012) · Critical Care · doi:10.1186/cc11407 · Cited by 574
Cited by
Devlin, J. W., Skrobik, Y., Gélinas, C., Needham, D. M., Slooter, A. J. C., Pandharipande, P. P., Watson, P. L., Weinhouse, G. L., Nunnally, M. E., Rochwerg, B., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003299 · Cited by 3,956
Self-citationEngelman, D. T., Ben Ali, W., Williams, J. B., Perrault, L. P., Reddy, V. S., Arora, R. C., Roselli, E. E., Khoynezhad, A., Gerdisch, M., Levy, J. H., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.1153 · Cited by 1,225
Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., MacLullich, A. M. J., Slooter, A. J. C., & Ely, E. W. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00223-4 · Cited by 1,200
Self-citationCOVID-19: ICU delirium management during SARS-CoV-2 pandemic
Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., & Ely, E. W. (2020) · Critical Care · doi:10.1186/s13054-020-02882-x · Cited by 506
Delirium in critical illness: clinical manifestations, outcomes, and management
Stollings, J. L., Kotfis, K., Chanques, G., Pun, B. T., Pandharipande, P. P., & Ely, E. W. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06503-1 · Cited by 446
Metadata
- Authors
- van den Boogaard, M., Slooter, A. J. C., Brüggemann, R. J. M., Schoonhoven, L., Beishuizen, A., Vermeijden, J. W., Pretorius, D., de Koning, J., Simons, K. S., Dennesen, P. J. W., Van der Voort, P. H. J., Houterman, S., van der Hoeven, J. G., Pickkers, P., and the REDUCE Study Investigators, van der Woude, M. C. E., Besselink, A., Hofstra, L. S., Spronk, P. E., van den Bergh, W., Donker, D. W., Fuchs, M., Karakus, A., Koeman, M., van Duijnhoven, M., & Hannink, G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-02-20
- Volume
- 319
- Issue
- 7
- Pages
- 680
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2793524874
- Cited by
- 276
- References
- 33
- FWCI
- 32.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2018.0160
- The paper
- van den Boogaard, M., Slooter, A. J. C., Brüggemann, R. J. M., Schoonhoven, L., Beishuizen, A., Vermeijden, J. W., Pretorius, D., de Koning, J., Simons, K. S., Dennesen, P. J. W., Van der Voort, P. H. J., Houterman, S., van der Hoeven, J. G., Pickkers, P., and the REDUCE Study Investigators, van der Woude, M. C. E., Besselink, A., Hofstra, L. S., Spronk, P. E., . . . Hannink, G. (2018). Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2018.0160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.